Venmax Drugs & Pharmaceuticals Ltd

NSE: VENMAX · BSE: 531015 · Pharmaceuticals & Biotechnology · 17 announcements

Share price: ₹14.89
Market cap: ₹13.08 Cr
Revenue (annual): ₹8.02 Cr
Net profit (annual): ₹0.25 Cr
P/E (TTM): 46.7×Sector 47.3×
Promoter holding: 10.46%-3.34% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 3 Financial Results 3 Board Meeting Date 3 Capital Structure Change 2 Acquisition 2 Debt & Borrowing 1 Board Meeting Outcome 1 Annual Report 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

30 Jul 2026 16:15 IST BSE

Capital Structure Change

Venmax Drugs & Pharmaceuticals Capital Structure Change

Venmax Drugs and Pharmaceuticals Ltd allotted 7,53,334 equity shares upon conversion of warrants at Rs. 20 per share. This conversion increases the company's equity capital.

Value: ₹1.51 Cr

Read the filing ↗

29 Jul 2026 19:24 IST BSE

Capital Structure Change

Venmax Drugs & Pharmaceuticals Capital Structure Change

Venmax Drugs and Pharmaceuticals allotted 21,47,665 equity shares upon warrant conversion for a consideration of Rs. 3.22 Crore. This increases the company's paid-up share capital.

Value: ₹3.22 Cr

Read the filing ↗